Stipple Bio Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$100M
- Investors
-
10
Stipple Bio General Information
Description
Operator of a biotechnology company intended to unlock cellular profiling and target discovery. The company offers epitope-level resolution technology for single-cell profiling and allows the identification of novel therapeutic targets and the development of precision therapies, enabling users with therapies for a wide range of solid and hematologic malignancies.
Contact Information
Website
www.stipple.bioCorporate Office
- 238 Main Street
- Cambridge, MA 02142
- United States
Corporate Office
- 238 Main Street
- Cambridge, MA 02142
- United States
Stipple Bio Timeline
Stipple Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series A) | 31-Mar-2026 | $100M | Completed | Pre-Clinical Trials | ||
| 2. Seed Round | 20-Dec-2024 | Completed | Pre-Clinical Trials | |||
| 1. Seed Round | 03-Jun-2022 | $12M | $12M | Completed | Pre-Clinical Trials |
Stipple Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed-1 | ||||||||
| Seed | 1,200,000 | $0.000100 | 6% | $10 | $10 | 1x | $10 | 1.41% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Stipple Bio Signals
Stipple Bio Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| GordonMD Global Investments | PE/Buyout | Minority | ||
| GV | Corporate Venture Capital | Minority | ||
| Lola Capital Partners | Venture Capital | Minority | ||
| Nextech Invest | Venture Capital | Minority | ||
| RA Capital Management | Asset Manager | Minority |
Stipple Bio Acquisitions (1)
Stipple Bio’s most recent deal was a Merger/Acquisition with Spotlight Therapeutics.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Spotlight Therapeutics | Merger/Acquisition | Biotechnology |
Stipple Bio FAQs
-
When was Stipple Bio founded?
Stipple Bio was founded in 2022.
-
Where is Stipple Bio headquartered?
Stipple Bio is headquartered in Cambridge, MA.
-
What is the size of Stipple Bio?
Stipple Bio has 9 total employees.
-
What industry is Stipple Bio in?
Stipple Bio’s primary industry is Biotechnology.
-
Is Stipple Bio a private or public company?
Stipple Bio is a Private company.
-
What is the current valuation of Stipple Bio?
The current valuation of Stipple Bio is .
-
What is Stipple Bio’s current revenue?
The current revenue for Stipple Bio is .
-
How much funding has Stipple Bio raised over time?
Stipple Bio has raised $121M.
-
Who are Stipple Bio’s investors?
GordonMD Global Investments, GV, Lola Capital Partners, Nextech Invest, and RA Capital Management are 5 of 10 investors who have invested in Stipple Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process